| Peter Stach, DPM | |
|
4770 Sw Watson Ave, Beaverton, OR 97005-0511 | |
| (503) 805-4720 | |
| (971) 223-0969 |
| Full Name | Peter Stach |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 7 Years |
| Location | 4770 Sw Watson Ave, Beaverton, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366965675 | NPI | - | NPPES |
| 500798722 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | DP198085 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bridge City Foot And Ankle Llc | 3577975762 | 2 |
News Archive
Restoring function after spinal cord injury, which damages the connections that carry messages from the brain to the body and back, depends on forming new connections between the surviving nerve cells. While there are some delicate surgical techniques that reconnect the nerves, researchers are also looking at ways to restore the connections themselves at a cellular level.
Researchers from the Department of Pharmacy at the University of Copenhagen have developed a cell line, which may be used to investigate new drugs and help predict whether they are able to enter the brain.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.
A quality improvement initiative in the Neonatal Intensive Care Unit (NICU) at Children's National Hospital led to a significant reduction in treatment with intravenous vancomycin, an antibiotic used for resistant gram positive infections, which is often associated with acute kidney injury.
Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).
› Verified 6 days ago
| Provider Name | Bridge City Foot & Ankle Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669074316 PECOS PAC ID: 3577975762 Enrollment ID: O20201211001474 |
News Archive
Restoring function after spinal cord injury, which damages the connections that carry messages from the brain to the body and back, depends on forming new connections between the surviving nerve cells. While there are some delicate surgical techniques that reconnect the nerves, researchers are also looking at ways to restore the connections themselves at a cellular level.
Researchers from the Department of Pharmacy at the University of Copenhagen have developed a cell line, which may be used to investigate new drugs and help predict whether they are able to enter the brain.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.
A quality improvement initiative in the Neonatal Intensive Care Unit (NICU) at Children's National Hospital led to a significant reduction in treatment with intravenous vancomycin, an antibiotic used for resistant gram positive infections, which is often associated with acute kidney injury.
Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Stach, DPM 4770 Sw Watson Ave, Beaverton, OR 97005-0511 Ph: (503) 805-4720 | Peter Stach, DPM 4770 Sw Watson Ave, Beaverton, OR 97005-0511 Ph: (503) 805-4720 |
News Archive
Restoring function after spinal cord injury, which damages the connections that carry messages from the brain to the body and back, depends on forming new connections between the surviving nerve cells. While there are some delicate surgical techniques that reconnect the nerves, researchers are also looking at ways to restore the connections themselves at a cellular level.
Researchers from the Department of Pharmacy at the University of Copenhagen have developed a cell line, which may be used to investigate new drugs and help predict whether they are able to enter the brain.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.
A quality improvement initiative in the Neonatal Intensive Care Unit (NICU) at Children's National Hospital led to a significant reduction in treatment with intravenous vancomycin, an antibiotic used for resistant gram positive infections, which is often associated with acute kidney injury.
Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).
› Verified 6 days ago
Dr. Peter Duy Pham, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 17200 Nw Corridor Ct Ste 108, Beaverton, OR 97006 Phone: 503-292-9252 | |
Kenneth K.s. Mah, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 14355 Sw Allen Blvd, Suite 120, Beaverton, OR 97005 Phone: 503-643-1737 Fax: 503-643-4926 | |
Bridge City Foot & Ankle Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 4770 Sw Watson Ave, Beaverton, OR 97005 Phone: 503-427-8967 Fax: 971-223-0096 | |
Brian Guy Orahood, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 17200 Nw Corridor Ct Ste 108, Beaverton, OR 97006 Phone: 503-292-9252 Fax: 503-992-6780 | |
Dr. Candace Lynn Gregory, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 14795 Sw Murray Scholls Dr Ste 121, Beaverton, OR 97007 Phone: 503-597-5647 Fax: 503-597-5640 | |
Oregon Foot And Ankle Specialists, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 17200 Nw Corridor Ct Ste 108, Beaverton, OR 97006 Phone: 503-292-9252 Fax: 503-992-6780 |